Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Sinovac Biotech, Ltd. (SVA : NSDQ)
 
 • Company Description   
Sonovac Biotech Ltd. specializes in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as hepatitis A and hepatitis B, influenza, `SARS`, and avian flu. Sinovac is one of the leading emerging biotechnology companies in China.

Number of Employees: 2,149

 
 • Price / Volume Information   
Yesterday's Closing Price: $6.47 Daily Weekly Monthly
20 Day Moving Average: 0 shares
Shares Outstanding: 99.50 (millions)
Market Capitalization: $643.78 (millions)
Beta: 39.13
52 Week High: $6.47
52 Week Low: $6.47
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.00% 9.16%
12 Week 0.00% 8.08%
Year To Date 0.00% 18.45%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
NO. 15 ZHI TONG ROAD ZHONGGUANCUN TECH PARK CHANGPING DISTR.
-
BEIJING,F4 102200
CHN
ph: 86-10-5693-1800
fax: 86-10-5693-1800
ir@sinovac.com http://www.sinovac.com
 
 • General Corporate Information   
Officers
Weidong Yin - Chairman and Chief Executive Officer
Nan Wang - Chief Financial Officer; Vice President
Simon Anderson - Director
Yuk Lam Lo - Director
Shan Fu - Director

Peer Information
Sinovac Biotech, Ltd. (CORR.)
Sinovac Biotech, Ltd. (RSPI)
Sinovac Biotech, Ltd. (CGXP)
Sinovac Biotech, Ltd. (BGEN)
Sinovac Biotech, Ltd. (GTBP)
Sinovac Biotech, Ltd. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: P8696W104
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: 07/29/22
Share - Related Items
Shares Outstanding: 99.50
Most Recent Split Date: (:1)
Beta: 39.13
Market Capitalization: $643.78 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/29/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.05
Price/Cash Flow: 0.07
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -
09/30/21 - -
Current Ratio
03/31/22 - -
12/31/21 - 6.18
09/30/21 - -
Quick Ratio
03/31/22 - -
12/31/21 - 6.03
09/30/21 - -
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - 90.65
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - 139.45
09/30/21 - -
Inventory Turnover
03/31/22 - -
12/31/21 - 2.74
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - 0.00
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - 0.13
09/30/21 - -
 

Powered by Zacks Investment Research ©